Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion
Abstract Background The mitogen-activated protein kinase (MAPK) signaling pathway is frequently hyperactivated in malignant melanoma and its inhibition has Catheters and Sheaths - Intermittent proved to be an efficient treatment option for cases harboring BRAFV600 mutations (BRAFMut).However, there is still a significant need for effective targeted